Elicio Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Elicio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Elicio Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Elicio Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $22k | 5.4k | 4.00 |
| 2025-03-31 | $99 | 16 | 6.19 |
| 2024-12-31 | $88 | 18 | 4.89 |
| 2024-09-30 | $91 | 18 | 5.06 |